Scientists recently discovered that glycyrrhizin, a substance taken from black licorice root, may reduce inflammation and ...
A new therapy that combines two existing drugs shows promise for patients with inflammatory bowel disease who have exhausted ...
IBD is an immune condition. Instead of peacefully coexisting with gut microbes, the immune system becomes overly reactive, ...
Researchers have developed a stem cell-based model of the human intestine that may transform how new IBD treatments are ...
Targeted dietary therapies can induce remission in 50%-80% of IBD patients; discover which protocols — EEN, CDED, and whole ...
Inflammatory bowel disease (IBD), affecting an estimated 6–8 million people worldwide, may soon be monitored with a simple ...
For too long you have suffered from inflammatory bowel disease (IBD) or irritable bowel syndrome (IBS). Crohn’s disease.
Chronic immune diseases are shaped by multiple inflammatory processes happening at the same time, each in different parts of ...
This report highlights various aspects regarding the care of patients with IBS, as discussed on Wednesday during sessions presented at the annual meeting of the American College of Gastroenterology.
Pharma Equity Group’s subsidiary Reponex takes key step forward in Inflammatory Bowel Disease with upcoming European patent grant ...